Lizette Borreli

Patients with AF with a high bleeding risk and a low stroke risk may benefit from LAAO over oral anticoagulation.

New and improved to provide a more modern and readable format for the latest neurology news for today’s neurologists.

Presenting at CMSC 2022, researchers sought to explain the relationship between RLS and quality of life, MS-related disability, and perception of level of disability in patients with MS.

Analiz Rodriguez, MD, a neurosurgeon in Arkansas, recounts her experience with misogynoir during her residency training and the toll it took on her as a Black woman.

In an American Academy of Neurology (AAN) survey, researchers assessed self-reported gender disparities experienced by US-based AAN members doing research in neurology.

In this episode, neurologist Michael Kornberg, MD, and rheumatologist Laura C. Cappelli, MD, speak with us about how to improve the management of patients with rheumatologic conditions with neurologic manifestations.

Gary Small, MD, and Sandra Bond Chapman, PhD, delve into the definition of brain health, how to preserve it at any age, and how to promote brain health to the public.

An AAO 2021 presentation reviewed clinical trial data of intravitreal pegcetacoplan, a targeted C3 inhibitor, in controlling lesion growth in patients with geographic atrophy.

Presenting at AAO 2021, researchers examined the efficacy of intravenous infusions of teprotumumab, an IGF-IR inhibitor, in patients with thyroid eye disease with low inflammation.

Neurava, an Indiana startup developing a wearable device to monitor the potential risk for sudden, unexpected death in epilepsy (SUDEP), receives funding to complete the final prototype.